Health News Releases

April 12, 2013 22:00

Medical Marijuana Inc. Reports Record First Quarter 2013 Revenue and Income

Medical Marijuana, Inc. (OTC:MJNA), a leading cannabis and hemp industry innovator, today is pleased to pre-announce its fourth quarter earnings. The company earned net income of approximately $5.52 m

April 11, 2013 10:05

Synergy Pharmaceuticals Inc. Announces Pricing of Public Offering of Common Stock

Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced the pricing of an underwritten public offering of 16,375,000 shar

April 10, 2013 09:54

Synergy Pharmaceuticals Inc. Announces Public Offering of Common Stock

Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that it is offering to sell an aggregate value of $90,000,000 of

March 21, 2013 16:07

N.Y. Times Best-Selling Author to Highlight 6th World Medical Tourism Congress

The Medical Tourism Association™ released today a preliminary line-up of speakers who will address up to 2,000 participants from over 90 countries during the 6th World Medical Tourism & Global Healthc

March 11, 2013 10:29

DIMEDI Attends KIMES 2013, Will Exhibit Upgraded ‘X-ray Film Scanner’

Professional medical devices company, DIMEDI Co., Ltd (CEO Nam Yun, www.demedi.co.kr), revealed that it will be attending the upcoming 29th KIMES (Korea International Medical + Hospital Equipment Show

March 08, 2013 15:05

BioLegend Receives ISO 9001:2008 and ISO 13485:2003 Certification

BioLegend in San Diego, CA, a leading provider of antibodies and reagents for biomedical research, has been granted ISO 9001:2008 certification for manufacturing and distribution of antibodies, protei

March 08, 2013 09:06

Vital Images, Inc. Receives 510(k) Clearance From the U.S. Food and Drug Administration for Its CT TAVR Planning Application

Vital Images, Inc., a Toshiba Medical Systems Group Company and leading provider of advanced visualization and analysis solutions for healthcare providers, received 510(k) clearance from the United St

February 27, 2013 08:26

New Report Recommends Public Health Focus on Harmful Drinking vs. Eliminating Consumption

The traditional public health perspective on alcohol and noncommunicable diseases is indicted in a new report from the International Center for Alcohol Policies (ICAP). “Alcohol misuse and global heal

February 22, 2013 15:46

Korea Raises Asian Standard in AMI Treatment

Specialists at home and abroad gathered to discuss how to reduce the mortality rates of acute myocardial infarction (AMI), which is the main cause of sudden death and leads to more than 9,000 deaths a

February 18, 2013 15:03

BIOTRONIK Ilesto 7 ICD/CRT-D Series With ProMRI(R) Technology Gains CE Approval

BIOTRONIK, the leading manufacturer of cardiovascular medical technology that is celebrating its 50th anniversary in 2013, announced today that the Ilesto 7 implantable cardioverter-defibrillator/card

February 12, 2013 08:29

i-SENS, selected as 2013 ‘Hi-Seoul Brand’

For the last three consecutive years, i-SENS, the biosensor expert was selected as ‘Hi-Seoul brand’ by the Seoul Metropolitan government and was appointed as Seoul’s excellent corporate brand. ‘Hi-

February 11, 2013 19:00

Synergy Pharmaceuticals to Begin Trading on The NASDAQ Global Market

Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that its common stock has been approved for listing on The NASDAQ

February 11, 2013 11:58

OxOnc Announces Agreement With Pfizer to Develop Crizotinib as First-Line and Second-Line Treatment for Patients With ROS1-Positive Non-Small Cell Lung Cancer

OxOnc Development LP, (OxOnc), today announced that it has entered into a co-development agreement with Pfizer Inc., to conduct a pivotal clinical trial of Pfizer's crizotinib, marketed under the trad

January 31, 2013 11:35

e2v Announces Turnkey Contract for Cancer Radiotherapy Equipment

e2v(http://www.e2v.com/), the innovative solutions provider, has announced that it has signed a new multi-year contract with Accuray Incorporated, based in Sunnyvale, California for the supply of comp

January 31, 2013 08:46

1 Millionth Blood Stem Cell Transplant Marks Major Medical Milestone

The collaborative work of medical scientists and physicians across the globe has resulted in a major medical milestone: the world's 1 millionth blood stem cell transplant, a procedure that has become

January 30, 2013 17:50

Pacific Biosciences Names TSMC Supplier of the Year

Pacific Biosciences of California, Inc., (Nasdaq:PACB), provider of the PacBio® RS High Resolution Genetic Analyzer, today recognized TSMC, the world‘s largest and premier dedicated semiconductor foun

January 30, 2013 17:38

Pacific Biosciences' Software Upgrade Enhances De Novo Genome Assembly, Variant Calling and cDNA Transcript Analysis

Pacific Biosciences of California, Inc. (Nasdaq:PACB) provider of the PacBio® RS High Resolution Genetic Analyzer, today announced it is releasing a new software upgrade that provides higher quality g

January 30, 2013 08:51

CareSens, awarded ‘’Korea First Brand Grand Prize' in Blood Glucose Meter Category for Two Consecutive Years

i-SENS announced, CareSens brand was awarded the grand prize for “2013 Korea First Brand Grand Prize” sponsored by Korea Consumer Brand Committee at the award ceremony on January 22nd. 11th annual

January 28, 2013 19:00

Synergy Pharmaceuticals Initiates Multiple Ascending Dose Phase Ib Trial in Healthy Volunteers of SP-333, a Second Generation Guanylate Cyclase C Agonist for the Treatment of Ulcerative Colitis

Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal (GI) disorders, announced today that oral dosing of healthy volunteers has begun in a Phase I clinical t

January 24, 2013 15:51

MATRIX Study to Explore Improved Detection and Management of Atrial Fibrillation with the Unique Lumax DX ICD

BIOTRONIK, a leading manufacturer of innovative medical technology, today announced the start of the large-scale international MATRIX study (Management and Detection of Atrial TachyarRhythmias in Pati

January 18, 2013 08:23

Synergy Pharmaceuticals Announces Closing of Merger With Callisto Pharmaceuticals

Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that its previously announced merger with Callisto Pharmaceutical

January 16, 2013 11:15

FDA Clears Apira Science's iGrow(R) Hair Growth Platform

Apira Science, Inc. (www.igrow2laser.com), a global leader in aesthetic light-based therapies, today announced that it has received 510(k) clearance from the United States Food and Drug Administration

January 15, 2013 19:00

Callisto Stockholders Approve Merger With Synergy Pharmaceuticals

Callisto Pharmaceuticals, Inc. (OTCQB:CLSP) (“Callisto”) today announced that it convened its special meeting of stockholders yesterday and it has received the necessary approvals from its stockholder